Tag: Single Firm Conduct

Displaying 1 - 15 of 15 results.

Filtering by content type: Press Release

Following the Federal Trade Commission’s decision not to petition the Supreme Court for review of the Qualcomm case, Acting Chairwoman Rebecca Kelly Slaughter issued this statement:
The Federal Trade Commission today sued Facebook, alleging that the company is illegally maintaining its personal social networking monopoly through a years-long course of anticompetitive conduct.
The Federal Trade Commission today filed a petition with the U.S. Court of Appeals for the Ninth Circuit requesting rehearing en banc of the August 11, 2020, decision of a panel of that court in the matter of FTC v. Qualcomm Incorporated.
Indivior, Inc. has agreed to pay $10 million to settle Federal Trade Commission charges that it violated antitrust laws through a deceptive scheme to thwart lower priced generic competition with its branded opioid replacement therapy drug Suboxone. The proposed stipulated order for a permanent...
Reckitt Benckiser Group plc has agreed to pay $50 million to settle Federal Trade Commission charges that it violated the antitrust laws through a deceptive scheme to thwart lower-priced generic competition to its branded drug Suboxone. Suboxone is a prescription oral medication used to minimize...
Federal Trade Commission Bureau of Competition Director Bruce Hoffman issued this statement regarding the U.S. District Court for the Northern District of California’s ruling yesterday that Qualcomm Inc.’s licensing practices relating to its modem chips violate Sections 1 and 2 of the Sherman Act...
The Federal Trade Commission has reached a settlement in FTC v. Actavis, the 2009 FTC case alleging that the brand-name drug company Solvay and three generic drug companies illegally agreed to restrict generic competition to Solvay’s branded testosterone-replacement drug AndroGel for nine years.
The Federal Trade Commission has approved a sublicense submitted by Mallinckrodt ARD Inc. granting West Therapeutic Development, LLC certain rights to develop and market the specialty drug Synacthen Depot in the United States.Synacthen Depot contains a synthetic version of adrenocorticotropic...
Mallinckrodt ARD Inc., formerly known as Questcor Pharmaceuticals, Inc., and its parent company, Mallinckrodt plc, have agreed to pay $100 million to settle Federal Trade Commission charges that they violated the antitrust laws when Questcor acquired the rights to a drug that threatened its...
By a unanimous vote, the Federal Trade Commission has determined that computer technology developer Rambus, Inc. unlawfully monopolized the markets for four computer memory technologies that have been incorporated into industry standards for dynamic random access memory – DRAM chips. DRAMs are...
Two consent orders announced by the Federal Trade Commission today both resolve the competitive concerns about Chevron Corporation’s (Chevron) proposed $18 billion acquisition of Unocal Corporation (Unocal), and settle the Commission’s 2003 monopolization complaint against Unocal alleging...
The Federal Trade Commission today reinstated charges that the Union Oil Company of California violated antitrust laws by defrauding the California Air Resources Board (CARB) in connection with regulatory proceedings regarding development of reformulated gasoline.
Chief Administrative Law Judge Stephen J. McGuire today issued his initial decision and order in the matter of Rambus, Inc. The order states "Accordingly, Complaint Counsel having failed to sustain its burden of establishing liability for the violations alleged, the Complaint is Dismissed." That...
The Federal Trade Commission today issued an administrative complaint against Union Oil Company of California (Unocal) for allegedly committing fraud in connection with regulatory proceedings before the California Air Resources Board (CARB) regarding the development of reformulated gasoline (RFG).